MSB 1.33% $1.14 mesoblast limited

Ann: P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment, page-5

  1. 7,752 Posts.
    lightbulb Created with Sketch. 2351
    This announcement doesn't even really say anything though, let's be honest. It just restates that Phase 2 trials had a meaningful result and now they hope to achieve the same with phase 3. We knew all this already
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.